Today, we’re going on a journey to explore the Biocon Share Price Target for the years 2023 to 2050. Biocon Limited is a leading biotechnology company based in Bangalore, India. Founded in 1978 by Kiran Mazumdar-Shaw, Biocon has grown to become a global player in the biotech industry, with a presence in over 120 countries.
The company’s mission is to harness the power of biotechnology to improve the quality of life for people around the world. Biocon’s success can be attributed to its focus on innovation, quality, and affordability.
The company has a diverse portfolio of products and services, ranging from biosimilars and novel biologics to research and development services. Biocon’s biosimilars are used to treat a range of diseases, including cancer, diabetes, and autoimmune disorders.
Overview of Biocon
| Name | Biocon Limited |
| Symbol | BIOCON |
| Industry | Biotechnology |
| Founded | 1978 |
| Headquarters | Bangalore, India |
| Services | Biosimilars, Novel Biologics, Research and Development Services |
| Country | India |
| Locations | Bangalore, Hyderabad, Chennai, Pune, Malaysia, UAE, Germany, UK, US |
| Website | biocon.com |
| Profile | Biocon |
One of Biocon’s key strengths is its commitment to research and development. The company has established partnerships with leading universities and research institutions in India and around the world to drive innovation and advance scientific knowledge. Biocon’s research efforts have resulted in numerous scientific publications and patents, demonstrating the company’s dedication to advancing science in the industry.
In recent years, Biocon has expanded its global footprint through strategic partnerships and acquisitions. In 2019, the company formed a partnership with Mylan to commercialize biosimilars in the US and Europe. Biocon has also acquired several companies, including a research and development unit from Pfizer and a manufacturing facility from Acacia Lifesciences.
Biocon’s success has not gone unnoticed. The company has received numerous awards and accolades for its contributions to the biotech industry and society at large. In 2020, Biocon was ranked among the top 10 biotech companies in the world by Forbes.
Keep an eye on Biocon’s share price today with real-time updates, and examine its performance on the stock market through comprehensive charts that display the fluctuations in Biocon’s stock price. we will also take into analyst recommendations from various brokerage firms at the end of the article.
Above, the chart presents historical prices for Biocon stock, illustrating its trending behavior. Below, the table provides detailed data on the stock’s open, high, low, and close prices, offering a comprehensive perspective for stock analysis.
Brokerage Firms
An effective method for evaluating the Biocon share price Target is by examining research reports and analyses conducted by reputable financial institutions and brokerage firms. The latest research reports are available on Biocon.
| DATE | AUTHOR | TARGET | TYPE |
|---|---|---|---|
| 17 NOV 2023 | Geojit BNP Paribas | 260.00 | Accum. |
| 13 NOV 2023 | Axis Direct | 250.00 | Hold |
| 12 NOV 2023 | Motilal Oswal | 220.00 | Neutral |
| 16 AUG 2023 | Geojit BNP Paribas | 273.00 | Hold |
| 14 AUG 2023 | Axis Direct | 260.00 | Hold |
| 13 AUG 2023 | ICICI Securities Limited | 230.00 | Sell |
| 29 MAY 2023 | Sharekhan | 266.00 | Hold |
| 25 MAY 2023 | Axis Direct | 260.00 | Hold |
| 25 MAY 2023 | ICICI Direct | 235.00 | Hold |
| 25 MAY 2023 | ICICI Securities Limited | 250.00 | Hold |
| 24 MAY 2023 | Motilal Oswal | 260.00 | Neutral |
| 09 MAR 2023 | Geojit BNP Paribas | 238.00 | Hold |
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Biocon price target for 2023, 2025 to 2030, based on our Research knowledge and forecasting.
Biocon has a strong pipeline of products that are expected to drive growth in the coming years. The company has made significant investments in research and development, which is expected to result in the launch of several new products in the near future. Additionally, Biocon has a strong presence in emerging markets, which is expected to drive growth in the coming years. Based on these factors, we expect the Biocon share price to reach a minimum of ₹280 and a maximum of ₹300 by the end of 2023.
In 2024, we expect Biocon to continue its growth trajectory, driven by the launch of new products and expansion into new markets. The company has a strong focus on biosimilars, which is a rapidly growing market. Additionally, Biocon has a strong presence in the insulin market, which is expected to continue to grow in the coming years. Based on these factors, we expect the Biocon share price to reach a minimum of ₹320 and a maximum of ₹350 by the end of 2024.
By 2025, we expect Biocon to have established itself as a leading player in the biopharmaceutical industry. The company’s strong focus on research and development is expected to result in the launch of several new products, which will drive growth in the coming years. Additionally, Biocon’s strong presence in emerging markets is expected to continue to drive growth. Based on these factors, we expect the Biocon share price to reach a minimum of ₹400 and a maximum of ₹450 by the end of 2025.
By 2027, we expect Biocon to have established itself as a leading player in the biopharmaceutical industry. The company’s strong focus on research and development is expected to result in the launch of several new products, which will drive growth in the coming years. Additionally, Biocon’s strong presence in emerging markets is expected to continue to drive growth. Based on these factors, we expect the Biocon share price to reach a minimum of ₹600 and a maximum of ₹650 by the end of 2027.
By 2030, we expect Biocon to have established itself as a dominant player in the biopharmaceutical industry. The company’s strong focus on research and development is expected to result in the launch of several new products, which will drive growth in the coming years. Additionally, Biocon’s strong presence in emerging markets is expected to continue to drive growth. Based on these factors, we expect the Biocon share price to reach a minimum of ₹900 and a maximum of ₹1000 by the end of 2030.
By 2035, we expect Biocon to have continued its growth trajectory, driven by the launch of new products and expansion into new markets. The company’s strong focus on biosimilars is expected to continue to drive growth, as is its strong presence in the insulin market. Additionally, Biocon’s investments in research and development are expected to result in the launch of several new products in the coming years. Based on these factors, we expect the Biocon share price to reach a minimum of ₹1500 and a maximum of ₹1700 by the end of 2035.
By 2040, we expect Biocon to have established itself as a dominant player in the biopharmaceutical industry. The company’s strong focus on research and development is expected to result in the launch of several new products, which will drive growth in the coming years. Additionally, Biocon’s strong presence in emerging markets is expected to continue to drive growth. The company’s investments in biosimilars and insulin are expected to continue to pay off, as these markets are expected to continue to grow in the coming years. Based on these factors, we expect the Biocon share price to reach a minimum of ₹2500 and a maximum of ₹3000 by the end of 2040.
By 2050, we expect Biocon to have established itself as a leader in the biopharmaceutical industry. The company’s strong focus on research and development is expected to result in the launch of several new products, which will drive growth in the coming years. Additionally, Biocon’s strong presence in emerging markets is expected to continue to drive growth.
The company’s investments in biosimilars and insulin are expected to continue to pay off, as these markets are expected to continue to grow in the coming years. Based on these factors, we expect the Biocon share price to reach a minimum of ₹5000 and a maximum of ₹6000 by the end of 2050.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2023 | ₹280 | ₹300 |
| 2024 | ₹320 | ₹350 |
| 2025 | ₹400 | ₹450 |
| 2026 | ₹500 | ₹550 |
| 2027 | ₹600 | ₹650 |
| 2030 | ₹900 | ₹1000 |
| 2035 | ₹1500 | ₹1700 |
| 2040 | ₹2500 | ₹3000 |
| 2050 | ₹5000 | ₹6000 |
Competitors of Biocon
| Name | P/E | Mar Cap Rs.Cr. |
|---|---|---|
| Sun Pharma.Inds. | 32.85 | 293954.50 |
| Cipla | 27.46 | 97495.65 |
| Dr Reddy’s Labs | 18.88 | 95926.83 |
| Zydus Lifesci. | 20.55 | 64168.67 |
| Aurobindo Pharma | 25.86 | 60873.15 |
| Lupin | 42.94 | 57272.57 |
| Alkem Lab | 36.79 | 55178.66 |
| Biocon | 35.71 | 28802.37 |
Fundamentals of Biocon
Analyst Recommendations
Biocon Buy or Sell
Daily Low / High
How to Buy Biocon Stock
- Click on the “Open an Account“
- Fill in the required details
- Complete the verifying your identity
- Login to Your Account
- Search for Biocon
- Place an Order.
| Telegram Channel | 👉 Click Here |
| WhatsApp Channel | 👉 Click Here |
– According to Google historical data, the price of Biocon on 8 April 2004 was ₹48.41
– As of 4 December 2023, the current share price of Biocon is ₹240.55 Check out today’s current share price.
– Based on our analysis, the maximum share price target for Biocon in 2023 could be ₹300.
To stay updated with the latest information related to the stock market and receive live stock market updates, follow Sharedhan and stay connected with us. Check out Today’s Share Market Open or Closed India.
I would like to remind you that I am not authorized by SEBI to provide any financial advice or recommendations. As you know, Share price prediction is not an exact science, That’s why I am conducting in-depth research and using different AI tools to predict share prices. My purpose is only educational, and I am using AI to see what the future of the stock might look like.
Disclaimer– These Share Price Targets for “Biocon Share Price Target” are only provided for informational purposes only. It does not constitute a recommendation to buy, sell, or hold Biocon stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions— Sharedhan.com
